Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Down 17.3%

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B) were down 17.3% on Friday . The stock traded as low as $279.91 and last traded at $279.91. Approximately 400 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 1,193 shares. The stock had previously closed at $338.55.

Bio-Rad Laboratories Stock Performance

The company has a 50-day moving average price of $327.49 and a two-hundred day moving average price of $317.66. The company has a current ratio of 5.83, a quick ratio of 4.34 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $7.98 billion, a P/E ratio of -13.03 and a beta of 0.66.

Bio-Rad Laboratories (NYSE:BIO.B) last posted its quarterly earnings data on Thursday, February 15th. The company reported $3.10 earnings per share for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.90% and a negative net margin of 23.86%. The firm had revenue of $681.18 million during the quarter.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.